Walmart
Recent News About Walmart
-
An Ohio county pays $500K of its opioid settlement to a pharma lobbyist not listed on court records
AKRON, Ohio (Legal Newsline) - An Ohio county that settled opioid lawsuits last year for $105 million paid more than $1 million in legal fees to two law firms that never appeared on any of the court filings, including one associated with a prominent Washington lobbyist whose firm represented multiple companies being sued by the county. -
ACLU concerned opioid judge is risking patients' privacy with recent order
CINCINNATI (Legal Newsline) – The ACLU is telling a federal appeals court that the judge overseeing thousands of opioid cases created a serious privacy issue when he ordered pharmacies to turn over 13 years’ worth of patient records. -
Pharmacies warn of possible massive data breach resulting from opioid judge's order
CINCINNATI (Legal Newsline) - The nation’s largest pharmacy chains have asked a federal appeals court to block an order requiring them to turn over more than a decade of nationwide prescription data, saying it could compromise the privacy rights of millions of consumers. -
Pharmacies facing opioid lawsuits file claims against doctors who did the prescribing
CLEVELAND (Legal Newsline) - Saying they have been unfairly targeted because of their deep pockets, pharmacies facing trial in opioid multidistrict litigation in Ohio later this year filed claims against hundreds of unnamed practitioners who may have written improper prescriptions for addictive painkillers. -
Without evidence and unable to make public nuisance argument, Delaware's opioid claims against Walgreens fail
WILMINGTON, Del. (Legal Newsline) - A Delaware judge has refused to certify the state’s appeal of an order dismissing its opioid claims against Walgreens, at least temporarily upholding a rare industry victory in litigation over the opioid crisis. -
Pharmacies feel opioid judge is meeting with plaintiffs lawyers behind their backs
CLEVELAND (Legal Newsline) - Pharmacy companies facing thousands of lawsuits over allegedly improper opioid prescriptions failed to convince the federal judge to prohibit out-of-court discussions with plaintiff lawyers that some defendants believe have affected them unfairly.